Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow-to-Debt Ratio
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow-to-debt ratio. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow-to-Debt Ratio of 0.70x as of September 2025, meaning its operating cash flow of CN¥504.02 Million could theoretically repay 1% of its total liabilities (CN¥719.98 Million) in one year. Check cash flow quality index of Chengdu Kanghong Pharmaceuticals Group C to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Cash flow-to-debt ratio of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. Historical debt coverage capacity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Check Chengdu Kanghong Pharmaceuticals Group C (002773) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow-to-Debt Ratio by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full cash flow conversion analysis, see Chengdu Kanghong Pharmaceuticals Group C operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 2.33x | CN¥1.50 Billion | CN¥645.22 Million | ▲ +14.7% |
| 2024 | 2.03x | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.7% |
| 2023 | 1.70x | CN¥1.22 Billion | CN¥717.76 Million | ▲ +49.3% |
| 2022 | 1.14x | CN¥925.15 Million | CN¥813.85 Million | ▲ +95.8% |
| 2021 | 0.58x | CN¥494.11 Million | CN¥851.08 Million | ▲ +164.9% |
| 2020 | 0.22x | CN¥273.32 Million | CN¥1.25 Billion | ▼ -67.4% |
| 2019 | 0.67x | CN¥812.15 Million | CN¥1.21 Billion | ▲ +113.1% |
| 2018 | 0.32x | CN¥350.88 Million | CN¥1.11 Billion | ▼ -57.1% |
| 2017 | 0.74x | CN¥766.86 Million | CN¥1.04 Billion | ▼ -25.9% |
| 2016 | 0.99x | CN¥846.35 Million | CN¥853.27 Million | ▼ -22.6% |
| 2015 | 1.28x | CN¥481.97 Million | CN¥376.19 Million | ▲ +44.7% |
| 2014 | 0.89x | CN¥291.38 Million | CN¥329.11 Million | ▼ -18.8% |
| 2013 | 1.09x | CN¥333.31 Million | CN¥305.69 Million | ▲ +45.2% |
| 2012 | 0.75x | CN¥281.84 Million | CN¥375.39 Million | ▲ +59.9% |
| 2011 | 0.47x | CN¥168.86 Million | CN¥359.58 Million | ▲ +25.7% |
| 2010 | 0.37x | CN¥136.79 Million | CN¥366.21 Million | ▼ -2.3% |
| 2009 | 0.38x | CN¥108.42 Million | CN¥283.73 Million | — |